DNA X, Inc. (SONM) Q1 2024 Annual Earnings
SONM·Reported May 14, 2024·Before market open
DNA X, Inc. reported Q1 2024 revenue of $16.8M, missed analyst consensus of $18.0M by $1.2M. Diluted EPS came in at $-0.70, missed the $-0.30 consensus by $0.40.
Revenue
$16.8Mmissed by $1.2M
Consensus: $18.0MDiluted EPS
$-0.70missed by $0.40
Consensus: $-0.30
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about DNA X, Inc. 's Q1 2024 earnings report.
DNA X, Inc. (SONM) reported Q1 2024 earnings on May 14, 2024 before market open.
DNA X, Inc. reported revenue of $16.8M and diluted EPS of $-0.70 for Q1 2024.
Revenue missed the consensus estimate of $18.0M by $1.2M. EPS missed the consensus estimate of $-0.30 by $0.40.
You can read the 10-K/A periodic report (0001493152-24-016057) directly on SEC EDGAR. The filing index links above go to sec.gov.